Mueller Water Products, Inc. (NYSE:MWA) announced that for its fiscal first quarter ended December 31, 2014, net sales were $261.8 million, an improvement of 1.7 percent over the prior year. Operating income was $8.1 million compared with $14.0 million in the prior year, and adjusted operating income was $16.3 million compared with $14.1 million in the prior year, an increase of 15.6 percent. On Wednesday shares of Mueller Water Products, Inc. (NYSE:MWA) closed at $8.92. Company’s sales growth for last 5 years was -3.70% and EPS growth for next 5 years is recorded as 10.00%.
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced that it has priced its previously announced underwritten public offering of common stock consisting of 10,000,000 shares at a public offering price of $8.75 per share. Gross proceeds to ZIOPHARM from this offering are expected to be approximately $87.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by ZIOPHARM. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) in last trading activity fell -4.24% to close at $8.58. Company weekly performance is 1.66% while its quarterly performance stands at 177.67%. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is -11.00% away from its 52 week high.
Effective with all orders entered January 30, 2015, and all orders shipping on or after March 2, 2015, Verso Corporation (NYSE:VRS) is increasing the transaction price of all Coated Freesheet, Coated Groundwood, Supercalendered and Economy Sheet grades, as the company said in the press release received by Lesprom Network. On last trading day Verso Corporation (NYSE:VRS) advanced 1.85% to close at $2.20. Its volatility for the week is 8.86% while volatility for the month is 7.83%. VRS’s sales growth for past 5 years was -4.70% and its EPS growth for past 5 years was -9.10%. Verso Corporation (NYSE:VRS) monthly performance is -34.72%.
Asterias Biotherapeutics, Inc. (NYSE MKT: AST) announced that it has commenced an underwritten public offering of its common stock. MLV & Co. LLC is acting as the Sole Book-Running Manager for the offering. The offering will be made pursuant to the Company’s existing effective shelf registration statement, previously filed with the Securities and Exchange Commission. Asterias Biotherapeutics, Inc. (NYSEMKT:AST) institutional ownership stands at 6.40%. In last trading activity company’s stock closed at $3.90.
Quanta Services, Inc. (NYSE:PWR) on 2 February has announced that Price Gregory International, a Quanta Services company, has been selected by Enbridge Energy, Limited Partnership for the Line 78 Pipeline Project. On last trading day Quanta Services, Inc. (NYSE:PWR) fell -2.72% to close at $28.23. Its volatility for the week is 3.78% while volatility for the month is 3.37%. PWR’s sales growth for past 5 years was 11.50% and its EPS growth for past 5 years was 16.50%. Quanta Services, Inc. (NYSE:PWR) monthly performance is 2.47%.